Literature DB >> 19258418

Prognosis for acute nontraumatic hemoperitoneum in the dog: a retrospective analysis of 60 cases (2003-2006).

Michael G Aronsohn1, Beata Dubiel, Brian Roberts, Barbara E Powers.   

Abstract

The complete medical records of 60 dogs with hemoabdomen were reviewed. All dogs underwent exploratory laparotomy and had a diagnosis established by a veterinary pathologist. Final diagnoses were hemangiosarcoma in 38 (63.3%) dogs, splenic hematoma in 16 (26.6%) dogs, splenic torsion in three (5%) dogs, hepatocellular carcinoma in two (3.3%) dogs, and carcinomatosis in one (1.6%) dog. Twenty-four (63.1%) dogs with hemangiosarcoma, 14 (87.5%) dogs with splenic hematoma, three (100%) dogs with splenic torsion, and two (100%) dogs with hepatocellular carcinoma were discharged from the hospital. Dogs with hemangiosarcoma were given a poor prognosis, while dogs with splenic hematoma, splenic torsion, and hepatocellular carcinoma were given a fair to good prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19258418     DOI: 10.5326/0450072

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN: 0587-2871            Impact factor:   1.023


  10 in total

1.  Hemoabdomen secondary to high grade lymphoma.

Authors:  Carolina Azevedo; Stephanie Schleis Lindley; Annette Smith; Kellye Joiner; Peter Christopherson
Journal:  Can Vet J       Date:  2017-07       Impact factor: 1.008

2.  Outcome and prognostic factors for dogs with a histological diagnosis of splenic hematoma following splenectomy: 35 cases (2001-2013).

Authors:  Steve G Patten; Sarah E Boston; Gabrielle J Monteith
Journal:  Can Vet J       Date:  2016-08       Impact factor: 1.008

3.  Partial splenectomy for incidentally detected non-ruptured splenic lesions in dogs: 18 cases (2004-2018).

Authors:  Kaustubh R Dongaonkar; Daniel Linden; Jacqueline R Davidson; Harry W Boothe; D Michael Tillson; Brad M Matz
Journal:  Can Vet J       Date:  2019-11       Impact factor: 1.008

4.  Development and validation of a multivariable model and online decision-support calculator to aid in preoperative discrimination of benign from malignant splenic masses in dogs.

Authors:  Kristine E Burgess; Lori Lyn Price; Ryan King; Manlik Kwong; Eliza Grant; Katherine A Olson; Jeremiah A Lyons; Nicholas A Robinson; Kristin M Wendelburg; John Berg
Journal:  J Am Vet Med Assoc       Date:  2021-06-15       Impact factor: 1.936

5.  A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.

Authors:  Janet A Grimes; Nripesh Prasad; Shawn Levy; Russell Cattley; Stephanie Lindley; Harry W Boothe; Ralph A Henderson; Bruce F Smith
Journal:  BMC Vet Res       Date:  2016-12-03       Impact factor: 2.741

6.  Histopathologic characteristics of biopsies from dogs undergoing surgery with concurrent gross splenic and hepatic masses: 125 cases (2012-2016).

Authors:  Fernando J Leyva; Catherine A Loughin; Curtis W Dewey; Dominic J Marino; Meredith Akerman; Martin L Lesser
Journal:  BMC Res Notes       Date:  2018-02-13

7.  Clinical Findings in Dogs Trained for Awake-MRI.

Authors:  Gregory S Berns; Mark Spivak; Sarah Nemanic; Nicole Northrup
Journal:  Front Vet Sci       Date:  2018-08-31

Review 8.  Review of oncological emergencies in small animal patients.

Authors:  Katrina L Tumielewicz; Danielle Hudak; Jennifer Kim; David W Hunley; Lisa A Murphy
Journal:  Vet Med Sci       Date:  2019-03-21

9.  Pre-operative Hemostatic Status in Dogs Undergoing Splenectomy for Splenic Masses.

Authors:  Jourdan B McPhetridge; Alex M Lynch; Cynthia R L Webster; Emily McCobb; A M de Laforcade; Therese E O'Toole
Journal:  Front Vet Sci       Date:  2022-04-25

10.  Characterizing circulating nucleosomes in the plasma of dogs with hemangiosarcoma.

Authors:  Heather Wilson-Robles; Tasha Miller; Jill Jarvis; Jason Terrell; Theresa Kathleen Kelly; Thomas Bygott; Mhammed Bougoussa
Journal:  BMC Vet Res       Date:  2021-06-29       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.